Disrupted Healthcare – Global Deals and Investments – 23 Transactions This Week

VC Deals (11 deals, $1400M)

Venus Medtech, a Chinese developer of percutaneous medicle devices, has raised $37 million in new equity funding from Goldman Sachs. Existing shareholders include Qiming Venture Partners and DiNova Venture Capital #asia

Emulate Inc., a Cambridge, Mass.-based developer of an automated human bioemulation platform, has raised $28.75 million in Series B funding. Backers Hansjörg Wyss, NanoDimension, Cedars-Sinai Medical Center, OS Fund, Atel Ventures and ALS Finding a Cure

Maxwell Health, a Boston-based HR platform for managing benefits and promoting employee health, has secured $22 million of a round that could total $35 million, according to a regulatory filing. Guardian Life Insurance Co. of America, Sun Life Financial and Cendana Capital were joined by return backers Adams Street Partners, Cambia Health Solutions, Catalyst Health Ventures, Industry Ventures, Lerer Hippeau Ventures, Schooner Capital, Tribeca Venture Partners and Vaizra Investments

LeSports, a Chinese digital eco-sports company that operates as an independently-funded subsidiary of LeEco, has raised $1.2 billion in Series B funding at a $2.1 billion pre-money valuation. HNA Group led the round, and was joined by Sun Honglei, Jia Nailiang and Liu Tao. The company previously raised a $123 million Series A round from Wanda Group and Yunfeng Capital #asia

Rythm, a French developer of a headset for improving sleep quality, has raised around $11 million in new VC and public grant funding

Gadeta BV, a Dutch developer of cancer immunotherapies based on gamma delta T cell receptors, has raised €7 million in Series A funding. Baxalta Ventures and Medicxi Ventures co-led the round, and were joined by Utrecht Holdings

Zavante Therapeutics, a San Diego-based developer of antibiotics, has raised $45 million in Series A funding (including the conversion of $10m in outstanding notes). Frazier Healthcare Partners and Longitude Capital co-led the round, and were joined by Aisling Capital

Wanliyun Medical Information Technology, a Chinese developer of cloud-based big data medical imaging platforms, has raised around $35 million in new funding led by the healthcare unit of Alibaba Group (NYSE: BABA) #asia

Gauss Surgical Inc., a Los Altos, Calif.-based maker of a real-time monitoring platform for surgical blood loss, has raised $12.6 million in Series B funding.Providence Health & Services led the round via its Providence Ventures investment arm, and was joined by Jump Capital and return backers Promus Ventures, LifeForce Ventures, Summation Health Ventures and the StanfordStartX Fund

Bangalore-based proactive healthcare provider, Touchkin, has raised $400K in seed funding from a few angel investors including Alok Mittal(ex-Canaan Partners), Amit Gupta (co-founder of InMobi), Anuj Srivastava (CEO of Livspace), Himanshu Aggarwal (CEO of Aspiring Minds), Raghunandan G(co-founder TaxiForSure), and Puneet Agarwal(co-founder of Moneyview) #asia

AddoDoc Technologies Pvt Ltd, which runs the Babygogo mobile app that connects parents with child healthcare experts, said on Tuesday it has raised $300,000 in a seed funding round led by angel investor Rajul Garg #asia

PE Deals (7 deals)

GTCR has agreed to acquire Vector Laboratories, a Burlingame, Calif.-based developer of labeling and detection systems for biologics, according to an FTC filing

Regina Maria, a Romania-based hospital and surgical center operator backed by Mid Europa Partners, has acquired Ponderas Hospital, a Bucharest medical facility focused on metabolic and bariatric surgery. No financial terms were disclosed

Advent International has agreed to acquire a majority ownership stake in ATI Physical Therapy, a Bolingbrook, Ill.-based outpatient physical therapy provider, fromKRG Capital Partners. No financial terms were disclosed

Affinity Equity Partners has acquired the general practitioner practice management software unit ofPrimary Health Care (ASX: PRY) for A$155 million

The Riverside Company has acquired a minority equity stake in Bentley Laboratories LLC, an Edison, N.J.-based company focused on the formulation and outsourced manufacturing of products for the beauty and OTC pharmaceutical industries. No financial terms were disclosed

PanTheryx Inc., a Boulder, Colo.-based maker of medical nutrition products, has raised $53 million in new financing from Pegasus Capital Advisors

Ares Management is in “pole position” to acquireDermatology Associates of Tyler, a Tyler, Texas-based provider of skin care services, from Candescent Partners

IPO Deals (2 deals)

After a somewhat quiet IPO scene, markets are expecting Q2 to se more activity

Aeglea BioTherapeutics Inc., an Austin, Texas-based developer of treatments for inborn errors of metabolism and therapies targeting tumor metabolism, has set its IPO terms to 3.5 million shares at between $16 and $18 per share. It would have a fully diluted market value of around $203 million, were it to price in the middle of its range. The pre-revenue company plans to trade on the Nasdaq under ticker symbol AGLE, with Cowen & Co., UBS and BMO Capital Markets serving as lead underwriters. Shareholders include Lilly Ventures (26.3% pre-IPO stake), Novartis Bioventures (25.6%), OrbiMed Advisors (7.1%) and Jennison Associates (5.7%), UT Horizon Fund, Venrock, RA Capital Management, Rock Springs Capital, Ally Bridge Group and Cowen Investments

Leejam Sports Co., a Saudi Arabia-based owner of the Fitness Time gym chain, is prepping an IPO, according to Bloomberg. The company is backed by Investcorp, and could seek upwards of $267 million in exchange for a 30% float

Other Deals (3 deals)

Veracyte Inc. (Nasdaq: VCYT) has secured up to $45 million in new financing, including a term loan agreement and securities purchase option, with Visium Healthcare Partners

Affymetrix (Nasdaq: AFFX), a Santa Clara, Calif.-based maker of molecular diagnostics equipment, is sticking with a $1.3 billion (or $14 per share) takeover offer fromThermo Fisher Scientific (NYSE: TMO), despite a $17 per share offer from a group of former executives andSummitView Capital (which has since been withdrawn)

Amplifon SpA (BIT: AMP) is bidding on Dutch hearing aid retailerAudioNova, according to Bloomberg. AudioNova currently is owned by HAL Trust, and could be valued at around 500 million. Other possible suitors include Sonova Holding, William Demant Holding and Sivantos AG (a portfolio company of EQT Partners)

Sources: Term Sheet, Financial Times, StrictlyVC, TechinAsia, CrunchBase, TechCrunch, Bloomberg, MobiHealthNews

The Propell Group

#healthtech #asia